Mayo Clinic, Rochester MN, USA.
Department of Medicine Merit Health River Region Hospital 2100 US-61, Vicksburg, MS 39183.
Acta Biomed. 2021 Feb 25;92(1):e2021036. doi: 10.23750/abm.v92i1.9083.
The American Diabetes Association and the Society of Critical Care Medicine recommend monitoring blood glucose (BG) every 1-2 hours in patients receiving insulin infusion to guide titration of insulin infusion to maintain serum glucose in the target range; however, this is based on weak evidence. We evaluated the compliance of hourly BG monitoring and relation of less frequent BG monitoring to glycemic status.
Retrospective chart review performed on 56 consecutive adult patients who received intravenous insulin infusion for persistent hyperglycemia in the ICU at Saint Vincent Hospital, a tertiary care community hospital an urban setting in Northeast region of USA. The frequency of fingerstick blood glucose (FSBG) readings was reviewed for compliance with hourly FSBG monitoring per protocol and the impact of FSBG testing at different time intervals on the glycemic status. Depending on time interval of FSBG monitoring, the data was divided into three groups: Group A (<90 min), Group B (91-179 min) and Group C (≥180 min).
The mean age was 69 years (48% were males), 77% patients had preexisting type 2 diabetes mellitus (T2DM). The mean MPM II score was 41. Of the 1411 readings for BG monitoring on insulin infusion, 467 (33%) were in group A, 806 (57%) in group B and 138 (10%) in group C; hourly BG monitoring compliance was 12.6%. The overall glycemic status was similar among all groups. There were 14 (0.99%) hypoglycemic episodes observed. The rate of hypoglycemic episodes was similar in all three groups (p=0.55).
In patients requiring insulin infusion for sustained hyperglycemia in ICU, the risk of hypoglycemic episodes was not significantly different with less frequent BG monitoring. The compliance to hourly blood glucose monitoring and ICU was variable, and hypoglycemic episodes were similar across the groups despite the variation in monitoring.
美国糖尿病协会和危重病医学会建议,在接受胰岛素输注的患者中,每 1-2 小时监测一次血糖(BG),以指导胰岛素输注的滴定,将血清葡萄糖维持在目标范围内;然而,这是基于薄弱的证据。我们评估了每小时 BG 监测的依从性以及较少频繁的 BG 监测与血糖状态的关系。
对在美国东北部城市三级保健社区医院圣文森特医院 ICU 中接受静脉胰岛素输注以治疗持续性高血糖的 56 例连续成年患者进行回顾性图表审查。根据方案审查了指血血糖(FSBG)读数的频率,以评估每小时 FSBG 监测的依从性以及 FSBG 测试在不同时间间隔对血糖状态的影响。根据 FSBG 监测的时间间隔,数据分为三组:A 组(<90 分钟)、B 组(91-179 分钟)和 C 组(≥180 分钟)。
平均年龄为 69 岁(48%为男性),77%的患者患有 2 型糖尿病(T2DM)。平均 MPM II 评分为 41。在胰岛素输注期间进行的 1411 次 BG 监测读数中,467(33%)在 A 组,806(57%)在 B 组,138(10%)在 C 组;每小时 BG 监测的依从性为 12.6%。所有组的总体血糖状态相似。观察到 14 例(0.99%)低血糖发作。所有三组的低血糖发作率相似(p=0.55)。
在 ICU 中需要胰岛素输注治疗持续高血糖的患者中,较少频繁的 BG 监测与低血糖发作的风险无显著差异。每小时血糖监测和 ICU 的依从性存在差异,尽管监测存在差异,但各组的低血糖发作相似。